Age-related macular degeneration: suitability of optogenetic therapy for geographic atrophy

Age-related macular degeneration: suitability of optogenetic therapy for geographic atrophy

Age-related macular degeneration (AMD) is a growing public health concern given the aging population and it is the leading cause of blindness in developed countries, affecting individuals over the age of 55 years. AMD affects the retinal pigment epithelium (RPE) and Bruch’s membrane in the macula, l...

Full description

Bibliographic Details
Main Authors: Grace A. Borchert, Hoda Shamsnajafabadi, Benjamin W. J. Ng, Kanmin Xue, Samantha R. De Silva, Susan M. Downes, Robert E. MacLaren, Jasmina Cehajic-Kapetanovic
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-07-01
Series:Frontiers in Neuroscience
Subjects:
optogenetic therapy
gene therapy
AMD
age-related macular degeneration
optogenetics
Online Access:https://www.frontiersin.org/articles/10.3389/fnins.2024.1415575/full

Internet

https://www.frontiersin.org/articles/10.3389/fnins.2024.1415575/full

Similar Items